A potential cure for type 1 diabetes has been identified by scientists in a new mouse study. In an animal study, researchers at Stanford School of Medicine discovered that resetting the immune system ...

A potential cure for type 1 diabetes has been identified by scientists in a new mouse study. In an animal study, researchers at Stanford School of Medicine discovered that resetting the immune system ...

COLUMBUS, Ohio (WCMH) — Ohio State is likely to end eight majors and phase out more than 260 courses in compliance with Senate Bill 1, Ohio’s sweeping higher education law. At the Nov. 20 Board of ...

Trailers for Season 2 of Landman hinted at some friction between Tommy Norris and his father. Given everything we learned about Billy Bob Thornton’s character in Season 1, it was only natural to start ...

Eli Lilly is releasing new Phase 3 trial results Tuesday. Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose approximately 23 ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with type 1 diabetes. When you purchase through links on our site, we may earn ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Obesity drugs were first approved to treat type ...

Veronica Paulus is a former STAT intern supported by the Harvard University Institute of Politics. GLP-1 drugs could treat more than just diabetes and obesity. They may also reduce migraine frequency.

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...

GLP-1 medications have become game changers for people trying to lose weight, but bariatric surgery is still superior when it comes to total and lasting weight loss, a new study has found. Patients ...

-- Company to host a live webcast event with an expert panel of clinicians during EHA2025 -- REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining ...

Researchers found that those living within a mile of golf courses have 126 percent higher risk of developing Parkinson's disease than those who live more than six miles away, according to a new study ...